HUM Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

03
Price $388.36
Market Cap (MRQ) $77.17B
P/E (TTM) 36.7
EPS (TTM) $10.59
Revenue (TTM) $145.68B
Div Yield 0.55%
ROE (TTM) 6.8%
Debt/Equity (MRQ) 0.6
52W Range $163–$429

HUM Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

04
range
bars

Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.

Stock splits 4
Ex-date Split Type
Aug. 1, 1991 3-for-2 Forward
Feb. 1, 1984 6-for-5 Forward
Feb. 1, 1983 4-for-3 Forward
Feb. 1, 1982 3-for-2 Forward

About Humana Inc. Common Stock Company overview from Wikipedia

05 · wikidata

Humana Inc. is an American for-profit health insurance company based in Louisville, Kentucky. In 2024, the company ranked 92 on the Fortune 500 list. It is the fourth largest health insurance provider in the U.S.

History

1961–1983: Nursing homes and hospitals

Lawyers David A. Jones Sr. and Wendell Cherry founded a nursing home company in 1961. The company, known in 1968 as Extendicare Inc., became the largest nursing home company in the United States. In 1972, Jones and Cherry sold the nursing home chain to purchase hospitals. Humana became one of the first two for-profit hospital ventures in the U.S. along with Hospital Corporation of America (HCA).

In 1974, the partners changed the corporate name to Humana Inc. It grew in the following years, both by business and in 1978 through the takeover of American Medicorp Inc., which doubled the company's size, and grew into the world's largest hospital company in the 1980s.

1984–present

As the American health care system changed in the 1980s, "one of its hospitals in Arizona lost a contract with the largest health-maintenance organization in the area [and] Humana created its own health insurance plan."

In 1993, Humana executives spun off hospital operations from health insurance operations to create Galen Health Care. The following year they sold the 73 hospitals of Galen Health Care Inc. to Nashville-based Columbia Hospital Corporation of America for $3.4 billion.

In 1998, one year after Jones had stepped aside as CEO, UnitedHealthcare made an unsuccessful attempt to acquire Humana. Humana pulled out of the acquisition after United stock dropped $2.9 billion in value.

In 2010, Humana returned to providing healthcare services when it bought Texas-based Concentra Inc., which owns urgent-care and physical therapy centers, for $790 million. They went on to sell Concentra again in 2015 for $1 billion.

In July 2015, Aetna announced that it would acquire Humana for $37 billion. However, the U.S. Department of Justice's Antitrust Division alleged the acquisition would be anticompetitive and sued to block the transaction. Following a trial, U.S. district judge John D. Bates of the United States District Court for the District of Columbia agreed and issued an injunction blocking the acquisition. In February 2017, Aetna and Humana cancelled a $34 billion merger agreement after judges ruled against the merger for a second time.

In July 2018, Humana joined two private equity firms in the acquisition of Kindred Healthcare. The deal provided Humana with a 40% stake in the company's home health, hospice and community care businesses, called "Kindred at Home," for approximately $800 million.

In 2021, Susan Diamond, formerly occupying an interim position, was announced to be the new permanent CFO.

In 2024 Humana announced that they would be leaving the Humana Building, which they had occupied since the 1980s, in order to cut costs. Humana said that it planned to consolidate its workforce in its Waterside-Clocktower campus.

In 2026 KFF reported that Humana was the second-largest parent organization for Medicare Advantage by overall enrollment, and that it had the largest growth in that sector that year.

Humana Military Healthcare Services

In 1993, Humana founded Humana Military Healthcare Services (HMHS) as a wholly owned subsidiary. They were awarded their first TRICARE contract in 1995, and began serving military beneficiaries in 1996.

In 2009, HMHS' contract with the military was awarded to United Military and Veterans Services, a subsidiary of UnitedHealth Group. HMHS protested that decision and the Government Accountability Office upheld the protest in late 2009.

Legal campaign against drug price fixing

Humana filed a lawsuit in August 2019, alleging that 37 defendants engaged in a “far-reaching conspiracy” to “blatantly fix the price” of generic drugs. This follows a similar smaller lawsuit from October 2018.

Controversy

In 1987, Humana sued NBC over a story line in the television medical drama St. Elsewhere in which the hospital was to be sold to a for-profit medical corporation and renamed "Ecumena", with subsequent changes to the hospital, both positive and negative, emanating from that change. The company claimed that the program infringed on the Humana trademark. Humana failed to block the airing of the show, but was successful at forcing NBC into showing a disclaimer at the beginning of the September 30 episode saying that the drama had no connection whatsoever with Humana.

On May 30, 1996, Linda Peeno, a physician who was contracted to work for Humana for nine months, testified before Congress as to the downside of managed care. Peeno said she was effectively rewarded by her employer for causing the death of a patient, because it saved the company a half-million dollars. Peeno stated that she felt the "managed care" model was inherently unethical.

In 1999, season one of Michael Moore's TV series The Awful Truth reported on Humana refusing to pay for a diabetic patient with pancreatic failure needing a transplant. The man's policy stated it covered all of his diabetes-related expenses, but another section of the policy stated that it did not cover organ transplants. Moore conducted a fake funeral on the front steps of the Humana building, and three days later Humana changed its policy and authorized the man's treatment.

Michael Moore's 2007 documentary Sicko used the video of Linda Peeno's testimony. On June 28, 2007, Humana declared that Peeno was never a Humana "associate" (permanent, full-time employee), but rather a "part-time contractor." Humana disputed portions of her Congressional testimony by saying that because the patient's healthcare plan did not cover heart transplants, denial of coverage was valid.

On September 21, 2009, the U.S. Dept. of Health and Human Services opened an investigation into Humana for sending flyers to Medicare recipients that the AARP characterized as deceptive. The mail was made to appear to contain official information about Medicare Advantage and prescription drug benefit information, but instead alleged that core Medicare benefits could be cut by the Obama administration's healthcare reform, a claim refuted by John Rother, AARP's executive vice president. Douglas Elmendorf, the head of the Congressional Budget Office (CBO), supported the claim that Medicare benefits could be cut, but his comments were in reference to just one of several congressional bills. CBO estimates of another healthcare reform bill found that changes to premiums would vary. The Centers for Medicare and Medicaid Services instructed Humana to cease all such mailings to Medicare plan members pending an investigation. HHS Secretary Kathleen Sebelius, in a letter to the insurance industry, threatened that bad actors may be excluded from new health insurance markets that were to open in 2014. Senate Republicans pointed out in a letter to Sebelius that a 1997 directive from the Centers for Medicare and Medicaid Services explicitly allowed HMOs to tell members about legislation and urge them to express opinions.

Source: Wikipedia, CC BY-SA 4.0 · View on Wikipedia ↗

Wikidata ↗

sectorHealth Care industryHealth Care employees67,060 countryUS

10-Year Performance Revenue, net income, margins and EPS trends

06
Revenue$129.66B
2016-12-31 → 2025-12-31
EPS$9.84
2016-12-31 → 2025-12-31
Free Cash Flow$375M
2016-12-31 → 2025-12-31
Net margin0.88%
2016-12-31 → 2025-12-31
Valuation & Ratios 07–12

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric 5Y trend HUM 5Y avg Peer Median Verdict
P/E (TTM) 36.75Y avg ≈23.6 ≈23.6 36.3 Overvalued
P/S (TTM) 0.55Y avg ≈0.7 ≈0.7 0.7 Undervalued
P/B (MRQ) 4.05Y avg ≈4.6 ≈4.6 3.9 Fair value
EV / EBITDA 25.85Y avg ≈19.0 ≈19.0 16.1 Fair value
Price / FCF (TTM) 39.65Y avg ≈54.2 ≈54.2 · ·
Price / Cash Flow (TTM) 30.45Y avg ≈29.3 ≈29.3 15.6 Overvalued
EV / Revenue (TTM) 0.45Y avg ≈0.6 ≈0.6 · ·
EV / FCF (TTM) 33.55Y avg ≈46.5 ≈46.5 · ·
Price / Tangible Book (MRQ) 4.35Y avg ≈14.5 ≈14.5 · ·

Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.

value · ≈ 5Y avg · industry median · verdict relative to median

Dividends Yield, payout ratio, dividend history, 5Y CAGR

13
Dividend Yield0.55%
Payout Ratio36.2%
Annualized Payout≈$3.54Paid quarterly
5Y Div CAGR≈7.2%Per share, split-adjusted
Ex-dateAmountCurrencyYield
Jun 26, 2026$0.89USD≈0.92%
Mar 27, 2026$0.89USD≈2.1%
Dec 26, 2025$0.89USD≈1.4%
Sep 26, 2025$0.89USD≈1.4%
Jun 27, 2025$0.89USD≈1.5%
Mar 28, 2025$0.89USD≈1.3%
Dec 31, 2024$0.89USD≈1.4%
Sep 30, 2024$0.89USD≈1.1%
Jun 28, 2024$0.89USD≈0.95%
Mar 27, 2024$0.89USD≈1.0%
Dec 28, 2023$0.89USD≈0.78%
Sep 28, 2023$0.89USD≈0.70%
Jun 29, 2023$0.89USD≈0.75%
Mar 30, 2023$0.89USD≈0.67%
Dec 29, 2022$0.79USD≈0.61%
Sep 29, 2022$0.79USD≈0.62%
Jun 29, 2022$0.79USD≈0.64%
Mar 30, 2022$0.79USD≈0.66%
Dec 30, 2021$0.70USD≈0.60%
Sep 29, 2021$0.70USD≈0.69%

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

14
Avg Surprise 6.5%
Next Report Nov 06, 2026
PeriodReportEPS ActualEPS EstSurprise
June 30, 2026 Jul 29, 2026 $7.61 $7.29 4.3%
March 31, 2026 $10.31 $10.29 0.21%
Dec. 31, 2025 $-3.96 $-4.05 2.1%
Sept. 30, 2025 $3.24 $2.85 13.8%
June 30, 2025 $6.27 $5.98 4.9%
March 31, 2025 $11.58 $10.17 13.9%

Full Fundamentals All metrics by year — income statement, balance sheet, cash flow

15
Income Statement 13
Metric Trend 202520242023202220212020201920182017201620152014
Revenue $129.66B$117.76B$106.37B$92.87B$83.06B$77.16B$64.89B$56.91B$53.77B$54.38B$54.29B$48.50B
SG&A Expense $15.45B$13.70B$13.19B$12.67B$10.12B$10.05B$7.38B$7.53B$6.57B$7.17B$7.29B$7.64B
Operating Income $2.70B$2.56B$4.01B$3.80B$3.15B$4.99B$3.19B$3.10B$4.26B$1.74B$2.35B$2.36B
Interest Expense ··$493M$401M$326M$283M$242M$218M$242M$189M$186M$192M
Other Non-op $-451M$-181M$-137M$-68M$532M$-103M$506M$-33M$0$0··
Pretax Income $1.44B$1.62B$3.33B$3.57B$3.42B$4.67B$3.47B$2.07B$4.02B$1.55B$2.43B$2.17B
Income Tax $250M$413M$836M$762M$485M$1.31B$763M$391M$1.57B$938M$1.16B$1.02B
Net Income $1.19B$1.21B$2.49B$2.81B$2.93B$3.37B$2.71B$1.68B$2.45B$614M$1.28B$1.15B
EPS (Basic) $9.87$10.01$20.09$22.20$22.79$25.47$20.20$12.24$16.94$4.11$8.54$7.44
EPS (Diluted) $9.84$9.98$20.00$22.08$22.67$25.31$20.10$12.16$16.81$4.07$8.44$7.36
Shares (Basic) 120,454,000120,571,000123,866,000126,419,000128,688,000132,199,000134,055,000137,486,000144,493,000149,375,000149,455,000154,187,000
Shares (Diluted) 120,826,000120,869,000124,441,000127,094,000129,396,000133,012,000134,727,000138,403,000145,585,000150,917,000151,142,000155,874,000
EBITDA $2.70B$2.56B$4.01B$3.80B$3.15B$4.99B$3.19B$3.10B$4.26B$1.74B$2.35B$2.36B
Balance Sheet 26
Metric Trend 202520242023202220212020201920182017201620152014
Cash & Equivalents $4.20B$2.22B$4.69B$5.06B$3.39B$4.67B$4.05B$2.34B$4.04B$3.88B$2.57B$1.94B
Short-term Investments $15.70B$18.21B$16.63B$13.88B$13.19B$12.55B$10.97B·····
Receivables $3.27B$2.70B$2.04B$1.67B$1.81B$1.14B$1.06B$1.01B$854M$1.28B$1.16B$1.05B
Other Current Assets $9.56B$6.68B$6.63B$5.57B$6.49B$5.28B$3.81B$3.56B$2.95B$3.44B$4.71B$4.01B
Current Assets $32.73B$29.82B$29.99B$26.18B$24.89B$23.64B$19.89B$16.95B$17.40B$16.19B$15.71B$15.54B
PP&E (Net) $2.23B$2.53B$3.03B$3.22B$3.07B$2.37B$1.96B$1.74B$1.58B$1.50B$1.38B$1.23B
PP&E (Gross) $5.52B$5.67B$5.88B$6.36B$5.95B$5.49B$4.62B$4.05B$3.56B$3.19B$2.72B$2.91B
Accum. Depreciation $3.29B$3.14B$2.85B$3.14B$2.87B$3.12B$2.66B$2.31B$1.98B$1.69B$1.34B$1.68B
Goodwill $9.69B$9.63B$9.55B$9.14B$11.09B$4.45B$3.93B$3.90B$3.28B$3.27B$3.27B$3.23B
Intangibles $1.13B$1.44B$1.69B$1.76B$2.64B$329M$177M$245M$226M$280M$357M$440M
Other Non-current Assets $3.13B$3.38B$3.38B$3.38B$4.38B$2.13B$1.83B$1.38B$2.17B$2.23B$2.48B$1.58B
Total Assets $48.91B$46.48B$47.06B$43.05B$44.36B$34.97B$29.07B$25.41B$27.18B$25.40B$24.68B$23.53B
Accounts Payable $5.72B$5.26B$6.57B$5.24B$4.51B$4.01B$3.75B$3.07B$4.07B$2.47B$2.21B$2.10B
Short-term Debt ·······$1.69B$150M$300M$299M$0
Current Liabilities $16.35B$16.94B$18.87B$17.18B$15.33B$13.39B$10.93B$10.08B$9.41B$7.82B$8.15B$7.47B
Capital Leases $418M$392M$444M$456M$546M$355M$332M·····
Other Non-current Liabilities $2.46B$1.95B$1.66B$1.47B$2.38B$1.79B$1.14B$581M$237M$263M$235M$236M
Total Liabilities $31.17B$30.03B$30.75B$27.68B$28.25B$21.24B$17.04B$15.25B$17.34B$14.71B$14.33B$13.88B
Total Debt $12.37B$11.14B$10.21B$9.03B$10.54B$6.06B$4.97B$6.07B$4.92B$4.09B$4.12B$3.83B
Common Stock $33M$33M$33M$33M$33M$33M$33M$33M$33M$33M$33M$33M
Retained Earnings $29.07B$28.32B$27.54B$25.49B$23.09B$20.52B$17.48B$15.07B$13.67B$11.45B$11.02B$9.92B
Treasury Stock $14.42B$14.37B$13.66B$12.16B$10.16B$9.92B$8.46B$7.32B$6.33B$3.30B$3.29B$2.86B
AOCI $-633M$-1.07B$-999M$-1.30B$42M$391M$156M$-159M$19M$-66M$58M$223M
Stockholders' Equity $17.66B$16.38B$16.26B$15.31B$16.08B$13.73B$12.04B$10.16B$9.84B$10.69B$10.35B$9.65B
Liabilities + Equity $48.91B$46.48B$47.06B$43.05B$44.36B$34.97B$29.07B$25.41B$27.18B$25.40B$24.68B$23.53B
Shares Outstanding 198,719,000198,719,000198,690,000198,667,000198,649,000198,649,000198,630,000·····
Cash Flow 17
Metric Trend 202520242023202220212020201920182017201620152014
D&A $698M$839M$779M$709M$596M··$444M$410M$388M$354M$328M
Stock-based Comp $241M$207M$175M$216M$180M$181M$163M$137M$157M$115M$109M$98M
Deferred Tax $75M$-192M$-164M$-100M$15M$195M$162M$194M$132M$-71M$-2M$-64M
Amort. of Intangibles $51M$60M$67M$81M$65M$88M$70M$90M$75M$77M$93M$121M
Restructuring ······$47M·$148M···
Operating Cash Flow $921M$2.97B$3.98B$4.59B$2.26B$5.64B$5.28B$2.17B$4.05B$1.94B$868M$1.62B
CapEx $546M$575M$1.00B$1.14B$1.34B$964M$736M$612M$524M$527M$523M$528M
Investing Cash Flow $2.27B$-2.95B$-3.49B$-1.01B$-6.56B$-3.06B$-1.28B$-3.09B$-2.94B$-1.36B$320M$-63M
Net Debt Issued ······$-400M$0$-800M$0$0$-500M
Stock Repurchased $151M$817M$1.57B$2.10B$79M$1.82B$1.07B$1.09B$3.37B$104M$385M$872M
Net Stock Activity $-151M$-817M$-1.57B$-2.10B$-79M$-1.82B$-1.07B$-1.09B$-3.37B$-104M$-385M$-872M
Dividends Paid $430M$431M$431M$392M$354M$323M$291M$265M$220M$177M$172M$172M
Financing Cash Flow $-1.22B$-2.49B$-856M$-1.91B$3.02B$-1.96B$-2.29B$-785M$-945M$732M$-552M$-758M
Net Change in Cash $1.98B$-2.47B$-367M$1.67B$-1.28B$619M$1.71B$-1.70B$165M$1.31B$636M$797M
Taxes Paid ·$570M$997M$758M$227M$1.13B$518M$631M$1.50B$916M$1.18B$1.03B
Free Cash Flow $375M$2.39B$2.98B$3.47B$946M$4.67B$4.55B$1.56B$3.52B$1.41B$345M$1.09B
Levered FCF ··$2.61B$3.15B$666M$4.47B$4.36B$1.38B$3.38B$1.33B$247M$989M
Profitability 7
Metric Trend 202520242023202220212020201920182017201620152014
Operating Margin 2.1%2.2%3.8%4.1%3.8%6.5%4.9%5.5%7.9%3.2%4.3%4.9%
Net Margin 0.92%1.0%2.3%3.0%3.5%4.4%4.2%3.0%4.5%1.1%2.4%2.4%
Pretax Margin 1.1%1.5%3.1%3.8%4.1%6.1%5.3%3.6%7.5%2.9%4.5%4.5%
EBITDA Margin 2.1%2.2%3.8%4.1%3.8%6.5%4.9%5.5%7.9%3.2%4.3%4.9%
ROA 2.5%2.6%5.5%6.4%7.4%10.5%9.9%6.4%9.3%2.5%5.3%5.2%
ROE 7.0%7.4%15.8%18.2%18.1%22.8%22.9%16.2%23.3%5.8%12.8%12.1%
ROIC 7.4%7.1%11.3%12.3%10.1%18.1%14.6%15.5%17.6%4.7%8.5%9.3%
Liquidity & Solvency 5
Metric Trend 202520242023202220212020201920182017201620152014
Current Ratio 2.01.81.61.51.61.81.81.71.92.11.92.0
Quick Ratio 1.41.41.21.21.21.40.50.30.50.70.50.4
Debt / Equity 0.70.70.60.60.70.40.40.60.50.40.40.4
LT Debt / Equity 0.70.70.60.60.70.40.40.40.50.40.40.4
Interest Coverage ··8.19.59.717.613.214.217.69.212.612.3
Efficiency 2
Metric Trend 202520242023202220212020201920182017201620152014
Asset Turnover 2.72.52.42.12.12.42.42.22.02.22.32.2
Receivables Turnover 43.449.757.453.356.370.362.760.950.444.649.045.8
Per Share 7
Metric Trend 202520242023202220212020201920182017201620152014
Book Value / Share $88.85$82.40$81.85$77.07········
Revenue / Share $1073.15$974.29$854.81$730.72$641.94$580.06$481.63$411.20$369.32$360.32$359.19$311.15
Cash Flow / Share $7.62$24.54$31.99$36.09$17.48$42.39$39.22$15.70$27.83$12.83$5.74$10.38
Cash / Share $21.14$11.18$23.62$25.47········
Dividend / Share ·········$1.16$1.15$1.11
Dividend Paid / Share $3.54$3.54$3.44$3.06$2.73$2.43$2.15$1.90$1.49$1.16$1.14$1.10
EPS (TTM) $9.84$9.98$20.00$22.08$22.67$25.31$20.10$12.16$16.81$4.07$8.44$7.36
Growth Rates 10
Metric Trend 202520242023202220212020201920182017201620152014
Revenue YoY 10.1%10.7%14.5%11.8%7.7%·······
Revenue CAGR 3Y 11.8%12.3%11.3%·········
Revenue CAGR 5Y 10.9%···········
EPS YoY -1.4%-50.1%-9.4%-2.6%-10.4%·······
EPS CAGR 3Y -23.6%-23.9%-7.5%·········
EPS CAGR 5Y -17.2%···········
Net Income YoY -1.6%-51.5%-11.3%-4.3%-12.9%·······
Net Income CAGR 3Y -24.9%-25.6%-9.6%·········
Net Income CAGR 5Y -18.8%···········
Dividends Paid CAGR 5Y 5.9%···········
Valuation (TTM) 17
Metric Trend 202520242023202220212020201920182017201620152014
Revenue TTM $129.66B$117.76B$106.37B$92.87B$83.06B$77.16B$64.89B$56.91B$53.77B$54.38B$54.29B$48.50B
Net Income TTM $1.19B$1.21B$2.49B$2.81B$2.93B$3.37B$2.71B$1.68B$2.45B$614M$1.28B$1.15B
Market Cap $50.90B$50.42B$90.96B$101.76B········
Enterprise Value $43.36B$41.13B$79.86B$91.85B········
P/E 26.025.422.923.220.516.218.223.614.850.121.219.5
P/S 0.40.40.91.1········
P/B 2.93.15.66.6········
P / Tangible Book 7.49.518.123.1········
P / Cash Flow 55.317.022.822.2········
P / FCF 135.721.130.629.3········
EV / EBITDA 16.016.119.924.2········
EV / FCF 115.617.226.826.5········
EV / Revenue 0.30.30.81.0········
Dividend Yield 0.84%0.85%0.47%0.39%········
Earnings Yield 3.8%3.9%4.4%4.3%4.9%6.2%5.5%4.2%6.8%2.0%4.7%5.1%
Payout Ratio 36.2%35.7%17.3%14.0%12.1%9.6%10.8%15.8%9.0%28.8%13.5%15.0%
Annual Payout $430M$431M$431M$392M$354M$323M$291M$265M$220M$177M$172M$172M

Most recent period on the left · null values shown as ·

Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years

16
Metric 2025-12-312024-12-312023-12-312022-12-312021-12-31
Revenue $129.66B $117.76B $106.37B $92.87B $83.06B
Operating Margin % 2.1% 2.2% 3.8% 4.1% 3.8%
Net Income $1.19B $1.21B $2.49B $2.81B $2.93B
Diluted EPS $9.84 $9.98 $20.00 $22.08 $22.67

Institutional owners (13F) 1,038 filers · $52.7B total · As of Sept. 30, 2026

17

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Holders 1,038
Value held $52.7B
New positions 248
Exited positions 85
Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
248 (+126 vs prior Q) 85 (-76 vs prior Q) 325 (+68 vs prior Q) 288 (-56 vs prior Q) +3.9M

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
Dodge & Cox $4,345,737,744 10,940,380 8.25% Shares
BlackRock, Inc. $4,138,159,785 10,417,803 7.85% Shares
VANGUARD GROUP INC $3,652,890,202 14,261,860 6.93% Shares
VANGUARD CAPITAL MANAGEMENT LLC $3,115,642,737 7,843,620 5.91% Shares
VANGUARD PORTFOLIO MANAGEMENT LLC $2,311,405,702 5,818,956 4.39% Shares
STATE STREET CORP $2,172,441,313 5,457,072 4.12% Shares
PZENA INVESTMENT MANAGEMENT LLC $1,749,013,682 4,403,136 3.32% Shares
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ $1,664,784,292 3,578,245 3.16% Shares
EAGLE CAPITAL MANAGEMENT LLC $1,528,010,749 3,846,762 2.90% Shares
Sessa Capital IM, L.P. $1,480,732,883 3,727,740 2.81% Shares
GEODE CAPITAL MANAGEMENT, LLC $1,337,386,742 3,369,757 2.54% Shares
JPMORGAN CHASE & CO $1,257,951,102 3,234,637 2.39% Shares
FMR LLC $1,157,405,236 2,913,763 2.20% Shares
Capital International Investors $950,462,637 2,392,826 1.80% Shares
GOLDMAN SACHS GROUP INC $913,562,254 2,299,889 1.73% Shares
NAYA CAPITAL MANAGEMENT UK LTD $728,407,339 1,833,763 1.38% Shares
NORGES BANK $694,505,009 1,748,414 1.32% Shares
Invesco Ltd. $587,403,999 1,478,788 1.11% Shares
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $544,521,489 1,370,831 1.03% Shares
MORGAN STANLEY $535,876,914 1,349,066 1.02% Shares
DIMENSIONAL FUND ADVISORS LP $445,839,059 1,122,669 0.85% Shares
Capital Research Global Investors $443,462,035 1,116,990 0.84% Shares
NORTHERN TRUST CORP $442,978,948 1,115,198 0.84% Shares
Slate Path Capital LP $428,969,795 1,079,930 0.81% Shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP $423,436,520 1,066,000 0.80% Put option
Capital World Investors $406,119,738 1,022,425 0.77% Shares
SUSQUEHANNA INTERNATIONAL GROUP, LLP $399,841,652 1,006,600 0.76% Call option
Newport Trust Company, LLC $384,768,345 968,653 0.73% Shares
CITADEL ADVISORS LLC $363,376,856 914,800 0.69% Call option
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC $348,908,912 878,377 0.66% Shares
Legal & General Group Plc $329,760,125 830,170 0.63% Shares
BARROW HANLEY MEWHINNEY & STRAUSS LLC $314,921,577 792,814 0.60% Shares
CITADEL ADVISORS LLC $310,904,094 782,700 0.59% Put option
Allianz Asset Management GmbH $307,098,329 773,119 0.58% Shares
WELLINGTON MANAGEMENT GROUP LLP $304,014,312 765,355 0.58% Shares
BANK OF AMERICA CORP /DE/ $279,490,113 703,615 0.53% Shares
VANGUARD FIDUCIARY TRUST CO $267,791,027 674,163 0.51% Shares
Maple Rock Capital Partners Inc. $249,553,862 628,251 0.47% Shares
Diamond Hill Capital Management, LLC (Investment Advisor) $245,555,446 618,185 0.47% Shares
Bank of New York Mellon Corp $238,144,113 599,527 0.45% Shares
GOLDMAN SACHS GROUP INC $232,333,978 584,900 0.44% Call option
MARSHALL WACE, LLP $216,873,381 545,978 0.41% Shares
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC $189,649,820 1,093,776 0.36% Shares
CITADEL ADVISORS LLC $178,360,519 449,022 0.34% Shares
High Ground Investment Management LLP $177,941,848 447,968 0.34% Shares
1832 Asset Management L.P. $176,401,430 444,090 0.33% Shares
BCV Asset Management Inc. $173,695,656 445,719 0.33% Shares
Nuveen, LLC $167,646,743 422,051 0.32% Shares
Holocene Advisors, LP $165,040,541 415,489 0.31% Shares
DEUTSCHE BANK AG\ $163,345,207 411,221 0.31% Shares

Show all 1,038 institutional owners →

Activists & 5%+ owners 1 position

18

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer Filed Stake Status Purpose Filing
David A. Jones ×2 filings Nov. 12, 2003 · Initial filing · SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Company insiders 79 insiders · 48 officers · 29 directors

19
Insider Role Last activity Shares owned Buys 12m Sells 12m Net 12m
James A. Rechtin President & CEO May 1, 2026 A 63,938 0 0 $0
Bruce D Broussard Chief Executive Officer Feb. 21, 2024 A 110,130 0 0 $0
Celeste Mellet Chief Financial Officer May 1, 2026 A 39,637 0 0 $0
Susan M Diamond Chief Financial Officer Dec. 31, 2024 J 20,165 0 0 $0
Brian A Kane Chief Financial Officer Feb. 22, 2021 A 24,342 0 0 $0
Steven E Mcculley Interim CFO & Treasurer May 9, 2014 G 14,916 0 0 $0
Aaron Martin President, Medicare Advantage May 1, 2026 A 25,237 0 0 $0
David Dintenfass President, Enterprise Growth May 1, 2026 A 25,407 0 0 $0
Sanjay K Shetty President, CenterWell May 1, 2026 A 22,088 1 0 $150,012
George Renaudin II President, Insurance March 31, 2026 J 16,075 0 0 $0
M.D. Andrew C. Agwunobi, Seg. President, Home Solutions Feb. 24, 2023 A 182 0 0 $0
Timothy Alan Wheatley Segment President, Retail Dec. 15, 2022 M 3,983 0 0 $0
Joseph William Jasser Seg. President, Care Delivery Dec. 15, 2017 M 222 0 0 $0
Thomas J Liston President - Retail Segment Feb. 18, 2014 A 105,443 0 0 $0
James E Murray EVP & COO March 31, 2017 J 34,668 0 0 $0
Shantanu Nundy Chief Medical Officer Sept. 1, 2026 A 2,549 0 0 $0
Japan Mehta Chief Information Officer May 1, 2026 A 17,176 0 0 $0
Michelle A. O'Hara Chief Human Resources Officer May 1, 2026 A 20,026 0 0 $0
Joseph C Ventura Chief Legal Officer May 1, 2026 A 27,405 0 0 $0
John-Paul W. Felter SVP, Chief Accting Off & Cont. Feb. 24, 2026 F 7,484 0 0 $0
Vishal Agrawal Chief Strat & Corp Dev Officer Feb. 24, 2025 A 16,717 0 0 $0
Timothy S. Huval Chief Administrative Officer Dec. 31, 2024 G 7,111 0 0 $0
Samir Deshpande Chief Information Officer Dec. 15, 2024 M 14,015 0 0 $0
William Kevin Fleming Chief Corporate Aff. Officer Feb. 21, 2024 A 11,723 0 0 $0
Susan D. Schick Seg Pres. Grp. & Military Bus. Feb. 24, 2023 F 3,687 0 0 $0
William H Shrank Chief Medical Officer May 1, 2022 M 4,294 0 0 $0
Cynthia H Zipperle SVP, Chief Acct Officer & Cont March 22, 2022 J 5,723 0 0 $0
Heather Cox Chief Dig Health & Analyt Off. Feb. 25, 2022 F 6,014 0 0 $0
Christopher H. Hunter Seg Pres. Gr. & Military Bus. March 16, 2021 G 8,168 0 0 $0
Elizabeth D Bierbower Strategic Advisor Dec. 18, 2019 M 18,092 0 0 $0
Brian P. Leclaire Strategic Advisor Dec. 15, 2019 M 6,339 0 0 $0
Jody L Bilney Chief Consumer Officer Feb. 25, 2019 A 9,774 0 0 $0
Roy A Beveridge, Chief Medical Officer Feb. 19, 2019 M 10,791 0 0 $0
Todoroff M Christopher Chief Legal Officer Dec. 15, 2018 M 11,136 0 0 $0
Heidi S Margulis Chief Corp. Affairs Officer Dec. 15, 2018 M 6,476 0 0 $0
Christopher E Kay SVP & Chief Innovation Officer March 17, 2017 M 4,361 0 0 $0
Tim S Mcclain Group Pres, Govt & Other Busin Feb. 18, 2014 A 1,101 0 0 $0
Bruce D Perkins Sgmt Pres, Healthcare Services Feb. 18, 2014 A 15,946 0 0 $0
Paul B. K. Kusserow Sr VP & Ch Strat Dev Officer June 24, 2013 M 19,347 0 0 $0
HATHCOCK BONNIE C Sr VP & Chief Human Res. Off Dec. 24, 2012 G 2,287 0 0 $0
Venkata R Madabhushi SVP & Chief Innov & Mrkting Of April 28, 2012 F 11,946 0 0 $0
GOODMAN BRUCE J Sr. VP Feb. 23, 2012 A 23,280 0 0 $0
Jonathan T Lord MD Sr VP & Chief Innovation Off. Feb. 4, 2009 I 0 0 0 $0
Arthur P Hipwell Senior Vice President March 27, 2008 J 302 0 0 $0
Kathleen Pellegrino VP and Acting General Counsel Feb. 25, 2008 F 13,836 0 0 $0
Steven O Moya Sr. VP-Chief Marketing Officer Dec. 31, 2007 I 0 0 0 $0
John M Bertko Vice President & Chief Actuary Feb. 23, 2007 M 57,548 0 0 $0
Eugene R Shields Senior Vice President-Gov Prgm Jan. 6, 2005 M 0 0 0 $0
Kurt J Hilzinger Director Sept. 30, 2026 A 19,448 0 0 $0
Paul John Smith Director Aug. 1, 2026 A 544 0 0 $0
Robert Stuart Field Director May 1, 2026 A 852 0 0 $0
Jorge S. Mesquita Director Jan. 2, 2026 A 4,127 0 0 $0
Frank A Damelio Director Jan. 2, 2026 A 20,634 0 0 $0
Raquel C. Bono Director Dec. 31, 2025 A 397 0 0 $0
Wayne A.I. Frederick Director Dec. 31, 2025 A 440 0 0 $0
Marcy S Klevorn Director Dec. 31, 2025 A 436 0 0 $0
John W Garratt Director Dec. 31, 2025 A 1,685 0 0 $0
David T Feinberg Director Dec. 31, 2025 A 1,207 0 0 $0
Karen Katz Director Dec. 31, 2025 A 590 0 0 $0
Brad D Smith Director Dec. 31, 2024 A 1,169 0 0 $0
William J. Mcdonald Director Jan. 2, 2024 A 2,276 0 0 $0
JONES DAVID A JR/KY Director Feb. 28, 2023 G 32,440 0 0 $0
OBRIEN JAMES J /KY Director Jan. 3, 2023 A 1,794 0 0 $0
Marissa T Peterson Director Jan. 3, 2022 A 2,044 0 0 $0
Frank Bisignano Director Jan. 4, 2021 A 2,727 0 0 $0
Webster Roy Dunbar Director Dec. 31, 2019 A 2,880 0 0 $0
Karen B Desalvo Director Jan. 2, 2019 A 634 0 0 $0
David Nash Director Jan. 2, 2019 A 112 0 0 $0
William Mitchell Director Dec. 31, 2018 A 688 0 0 $0
Michael B Mccallister Director Dec. 31, 2013 M 113,885 0 0 $0
Ann W Reynolds Director May 15, 2011 M 39,727 0 0 $0
James O Robbins Director Jan. 3, 2007 A · 0 0 $0
HALL JOHN R /KY Director Jan. 3, 2006 A 22,423 0 0 $0
JONES DAVID A SR/KY Director April 5, 2005 G 4,777,524 0 0 $0
Michael E Gellert Director Jan. 3, 2005 A 60,237 0 0 $0
Irwin Lerner Director Jan. 2, 2004 A 30,637 0 0 $0
Frederick John Crawford · Aug. 1, 2026 A 544 0 0 $0
Gordon Smith · Dec. 31, 2025 A 765 0 0 $0
James H Bloem · Nov. 7, 2013 M 30,326 0 0 $0

Insiders from SEC Form 3/4/5 filings; net = open-market P/S only

ETF ownership Held by 143 ETFs

20

Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.

Fund Weight Units As of Source
IHF · iShares Trust 4.63% 151,582 SH Sept. 11, 2026 Daily
FMTM · EA Series Trust 3.07% 21,303 NS July 31, 2026 N-PORT
TGLB · T. Rowe Price Exchange-Traded Funds… 2.57% 1,854 NS July 31, 2026 N-PORT
RPV · Invesco Exchange-Traded Fund Trust 2.35% 103,450 SH Oct. 2, 2026 Daily
SRHQ · Elevation Series Trust 2.31% 13,473 NS July 31, 2026 N-PORT
EPMV · Harbor ETF Trust 1.75% 225 NS July 31, 2026 N-PORT
CVAR · ETF Opportunities Trust 1.71% 2,014 NS July 31, 2026 N-PORT
RSPH · Invesco Exchange-Traded Fund Trust 1.57% 35,951 SH Oct. 2, 2026 Daily
NUMV · Nushares ETF Trust 1.39% 16,939 NS July 31, 2026 N-PORT
JDOC · J.P. Morgan Exchange-Traded Fund Tr… 1.16% 290 NS July 31, 2026 N-PORT
FVAL · FIDELITY COVINGTON TRUST 0.88% 32,276 NS July 31, 2026 N-PORT
VOE · VANGUARD INDEX FUNDS 0.82% 771,237 SH Aug. 19, 2026 Daily
IYH · iShares Trust 0.78% 70,303 SH Sept. 11, 2026 Daily
JOET · Virtus ETF Trust II 0.74% 4,940 NS July 31, 2026 N-PORT
PALC · Pacer Funds Trust 0.74% 4,248 NS July 31, 2026 N-PORT
RWL · Invesco Exchange-Traded Fund Trust … 0.71% 181,374 SH Oct. 2, 2026 Daily
VHT · VANGUARD WORLD FUND 0.70% 360,880 SH Aug. 19, 2026 Daily
PDP · Invesco Exchange-Traded Fund Trust 0.70% 27,208 SH Oct. 2, 2026 Daily
FHLC · FIDELITY COVINGTON TRUST 0.63% 57,108 NS July 31, 2026 N-PORT
IXJ · iShares Trust 0.61% 63,215 SH Sept. 11, 2026 Daily
CURE · Direxion Shares ETF Trust 0.50% 2,362 NS July 31, 2026 N-PORT
IWS · iShares Trust 0.47% 179,478 SH Sept. 11, 2026 Daily
VO · VANGUARD INDEX FUNDS 0.46% 2,601,869 SH Aug. 19, 2026 Daily
IMCV · iShares Trust 0.40% 11,586 SH Sept. 11, 2026 Daily
MTUM · iShares Trust 0.37% 227,558 SH Sept. 11, 2026 Daily
IWR · iShares Trust 0.35% 492,212 SH Sept. 11, 2026 Daily
PRF · Invesco Exchange-Traded Fund Trust 0.34% 88,063 SH Oct. 2, 2026 Daily
IMCB · iShares Trust 0.34% 14,123 SH Sept. 11, 2026 Daily
VRP · Invesco Exchange-Traded Fund Trust … 0.33% 10,420,000 Oct. 2, 2026 Daily
FFLC · FIDELITY COVINGTON TRUST 0.32% 10,722 NS July 31, 2026 N-PORT
IUS · Invesco Exchange-Traded Self-Indexe… 0.32% 8,116 SH Oct. 2, 2026 Daily
IMCG · iShares Trust 0.27% 27,157 SH Sept. 11, 2026 Daily
XOEF · iShares Trust 0.27% 151 SH Sept. 11, 2026 Daily
VLUE · iShares Trust 0.26% 62,879 SH Sept. 11, 2026 Daily
PFIG · Invesco Exchange-Traded Fund Trust … 0.25% 320,000 Oct. 2, 2026 Daily
SIZE · iShares Trust 0.24% 2,599 SH Sept. 11, 2026 Daily
BSCS · Invesco Exchange-Traded Self-Indexe… 0.23% 8,027,000 Oct. 2, 2026 Daily
ROUS · Lattice Strategies Trust 0.23% 4,462 NS July 31, 2026 N-PORT
BSCR · Invesco Exchange-Traded Self-Indexe… 0.22% 9,983,000 Oct. 2, 2026 Daily
EUSA · iShares, Inc. 0.22% 10,324 SH Sept. 11, 2026 Daily
HELO · J.P. Morgan Exchange-Traded Fund Tr… 0.21% 26,395 NS July 31, 2026 N-PORT
CATH · Global X Funds 0.21% 7,419 NS July 31, 2026 N-PORT
VYM · VANGUARD WHITEHALL FUNDS 0.20% 479,438 SH Aug. 19, 2026 Daily
RSP · Invesco Exchange-Traded Fund Trust 0.19% 487,833 SH Oct. 2, 2026 Daily
EVUS · iShares Trust 0.19% 1,842 SH Sept. 11, 2026 Daily
USXF · iShares Trust 0.19% 7,125 SH Sept. 11, 2026 Daily
ESMV · iShares Trust 0.19% 37 SH Sept. 11, 2026 Daily
SUSA · iShares Trust 0.19% 19,078 SH Sept. 11, 2026 Daily
ACVF · ETF Opportunities Trust 0.19% 790 NS July 31, 2026 N-PORT
VTV · VANGUARD INDEX FUNDS 0.18% 1,140,642 SH Aug. 19, 2026 Daily
DFLV · Dimensional ETF Trust 0.18% 32,943 NS July 31, 2026 N-PORT
JVAL · J.P. Morgan Exchange-Traded Fund Tr… 0.17% 3,921 NS July 31, 2026 N-PORT
VFVA · VANGUARD WELLINGTON FUND 0.17% 3,648 SH Aug. 19, 2026 Daily
DFSU · Dimensional ETF Trust 0.17% 10,472 NS July 31, 2026 N-PORT
IVE · iShares Trust 0.16% 200,080 SH Sept. 11, 2026 Daily
VOOV · VANGUARD ADMIRAL FUNDS 0.16% 27,648 SH Aug. 19, 2026 Daily
IUSV · iShares Trust 0.15% 104,740 SH Sept. 11, 2026 Daily
VEGN · ETF Series Solutions 0.15% 709 NS July 31, 2026 N-PORT
DFUV · Dimensional ETF Trust 0.14% 60,086 NS July 31, 2026 N-PORT
SUSL · iShares Trust 0.14% 4,238 SH Sept. 11, 2026 Daily
FYEE · Fidelity Greenwood Street Trust 0.14% 839 NS July 31, 2026 N-PORT
DSI · iShares Trust 0.14% 18,418 SH Sept. 11, 2026 Daily
IQSU · New York Life Investments ETF Trust 0.14% 1,230 NS July 31, 2026 N-PORT
CHRI · Global X Funds 0.13% 29 NS July 31, 2026 N-PORT
VONV · VANGUARD SCOTTSDALE FUNDS 0.13% 72,504 SH Aug. 19, 2026 Daily
IWD · iShares Trust 0.13% 267,199 SH Sept. 11, 2026 Daily
BSCT · Invesco Exchange-Traded Self-Indexe… 0.12% 3,809,000 Oct. 2, 2026 Daily
NULV · Nushares ETF Trust 0.11% 6,797 NS July 31, 2026 N-PORT
ESGU · iShares Trust 0.11% 47,962 SH Sept. 11, 2026 Daily
DGRO · iShares Trust 0.10% 111,232 SH Sept. 11, 2026 Daily
EGLE · Global X Funds 0.10% 6 NS July 31, 2026 N-PORT
GLBL · Pacer Funds Trust 0.10% 3 NS July 31, 2026 N-PORT
LQAI · Exchange Listed Funds Trust 0.10% 6 NS July 31, 2026 N-PORT
EQAL · Invesco Exchange-Traded Fund Trust … 0.09% 1,886 SH Oct. 2, 2026 Daily
TOPC · iShares Trust 0.09% 72 SH Sept. 11, 2026 Daily
ILCV · iShares Trust 0.08% 2,783 SH Sept. 11, 2026 Daily
XVV · iShares Trust 0.08% 1,375 SH Sept. 11, 2026 Daily
VV · VANGUARD INDEX FUNDS 0.08% 140,219 SH Aug. 19, 2026 Daily
ESGV · VANGUARD WORLD FUND 0.08% 27,152 SH Aug. 19, 2026 Daily
QVML · Invesco Exchange-Traded Fund Trust … 0.08% 3,447 SH Oct. 2, 2026 Daily
DFAC · Dimensional ETF Trust 0.08% 100,648 NS July 31, 2026 N-PORT
XTR · Global X Funds 0.08% 10 NS July 31, 2026 N-PORT
IVV · iShares Trust 0.07% 1,513,176 SH Sept. 11, 2026 Daily
ILCB · iShares Trust 0.07% 2,328 SH Sept. 11, 2026 Daily
XCLR · Global X Funds 0.07% 7 NS July 31, 2026 N-PORT
VOO · VANGUARD INDEX FUNDS 0.07% 3,119,147 SH Aug. 19, 2026 Daily
VTI · VANGUARD INDEX FUNDS 0.07% 3,812,375 SH Aug. 19, 2026 Daily
VONE · VANGUARD SCOTTSDALE FUNDS 0.07% 19,809 SH Aug. 19, 2026 Daily
VTHR · VANGUARD SCOTTSDALE FUNDS 0.07% 10,113 SH Aug. 19, 2026 Daily
PBP · Invesco Exchange-Traded Fund Trust 0.07% 715 SH Oct. 2, 2026 Daily
PBUS · Invesco Exchange-Traded Fund Trust … 0.07% 20,848 SH Oct. 2, 2026 Daily
IYY · iShares Trust 0.07% 5,172 SH Sept. 11, 2026 Daily
IWB · iShares Trust 0.07% 82,919 SH Sept. 11, 2026 Daily
XYLD · Global X Funds 0.07% 6,091 NS July 31, 2026 N-PORT
PTLC · Pacer Funds Trust 0.07% 6,112 NS July 31, 2026 N-PORT
BBUS · J.P. Morgan Exchange-Traded Fund Tr… 0.07% 16,615 NS July 31, 2026 N-PORT
USCL · iShares Trust 0.07% 4,768 SH Sept. 11, 2026 Daily
VOTE · TCW ETF Trust 0.07% 2,035 NS July 31, 2026 N-PORT
BKLC · BNY Mellon ETF Trust 0.07% 10,127 NS July 31, 2026 N-PORT
XRMI · Global X Funds 0.07% 92 NS July 31, 2026 N-PORT
IWV · iShares Trust 0.07% 33,101 SH Sept. 11, 2026 Daily
ITOT · iShares Trust 0.07% 156,223 SH Sept. 11, 2026 Daily
LRGF · iShares Trust 0.06% 5,842 SH Sept. 11, 2026 Daily
DXUV · Dimensional ETF Trust 0.06% 959 NS July 31, 2026 N-PORT
DFUS · Dimensional ETF Trust 0.06% 36,333 NS July 31, 2026 N-PORT
XYLG · Global X Funds 0.06% 111 NS July 31, 2026 N-PORT
SPUU · Direxion Shares ETF Trust 0.06% 453 NS July 31, 2026 N-PORT
ILCG · iShares Trust 0.06% 4,804 SH Sept. 11, 2026 Daily
QDPL · Pacer Funds Trust 0.06% 2,883 NS July 31, 2026 N-PORT
TOV · EA Series Trust 0.06% 454 NS July 31, 2026 N-PORT
TILT · FlexShares Trust 0.06% 3,564 NS July 31, 2026 N-PORT
DFAU · Dimensional ETF Trust 0.06% 20,053 NS July 31, 2026 N-PORT
PHDG · Invesco Actively Managed Exchange-T… 0.06% 95 SH Oct. 2, 2026 Daily
VOXP · Advisors Series Trust 0.06% 9 NS July 31, 2026 N-PORT
TOK · iShares Trust 0.06% 333 SH Sept. 11, 2026 Daily
HCMT · Direxion Shares ETF Trust 0.05% 835 NS July 31, 2026 N-PORT
DCOR · Dimensional ETF Trust 0.05% 4,948 NS July 31, 2026 N-PORT
URTH · iShares, Inc. 0.05% 10,772 SH Sept. 11, 2026 Daily
SPXL · Direxion Shares ETF Trust 0.05% 9,382 NS July 31, 2026 N-PORT
ACWI · iShares Trust 0.05% 38,539 SH Sept. 11, 2026 Daily
VT · VANGUARD INTERNATIONAL EQUITY INDEX… 0.04% 196,805 SH Aug. 19, 2026 Daily
OMFL · Invesco Exchange-Traded Self-Indexe… 0.04% 4,718 SH Oct. 2, 2026 Daily
NEAR · iShares U.S. ETF Trust 0.03% 1,504,000 SH Sept. 11, 2026 Daily
GLOF · iShares Trust 0.02% 106 SH Sept. 11, 2026 Daily
DYNF · BlackRock ETF Trust 0.01% 14,919 SH Sept. 11, 2026 Daily
CRBN · iShares Trust 0.01% 383 SH Sept. 11, 2026 Daily
VXUS · VANGUARD STAR FUNDS 0.00% 4,397,881 SH Aug. 19, 2026 Daily
VPL · VANGUARD INTERNATIONAL EQUITY INDEX… 0.00% 401,850 SH Aug. 19, 2026 Daily
VSS · VANGUARD INTERNATIONAL EQUITY INDEX… 0.00% 932,492 SH Aug. 19, 2026 Daily
VEA · VANGUARD TAX-MANAGED FUNDS 0.00% 2,391,019 SH Aug. 19, 2026 Daily
VSGX · VANGUARD WORLD FUND 0.00% 54,062 SH Aug. 19, 2026 Daily
BIV · VANGUARD BOND INDEX FUNDS · · July 15, 2026 Daily
BLV · VANGUARD BOND INDEX FUNDS · · July 15, 2026 Daily
BSV · VANGUARD BOND INDEX FUNDS · · July 15, 2026 Daily
BND · VANGUARD BOND INDEX FUNDS · · July 15, 2026 Daily
VUSB · VANGUARD BOND INDEX FUNDS · · July 15, 2026 Daily
VPLS · VANGUARD MALVERN FUNDS · · July 15, 2026 Daily
VCSH · VANGUARD SCOTTSDALE FUNDS · · July 15, 2026 Daily
VCIT · VANGUARD SCOTTSDALE FUNDS · · July 15, 2026 Daily
VCLT · VANGUARD SCOTTSDALE FUNDS · · July 15, 2026 Daily
VTC · VANGUARD SCOTTSDALE FUNDS · · July 30, 2026 Daily
BNDW · VANGUARD SCOTTSDALE FUNDS · · July 30, 2026 Daily
VCEB · VANGUARD WORLD FUND · · July 30, 2026 Daily

HUM Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

21
rating · 33 analysts BUY
Median target $420.00 +8.1%
8 24.2% Strong Buy
8 24.2% Buy
16 48.5% Hold
1 3.0% Sell
0 0.0% Strong Sell

12-Month Price Target

23 analysts · 2026-09-30

Mean target $423.74 +9.1%

Now Current price $388.36
Low$280.00 Mean$423.74 High$515.00

Peer comparison (GICS sub-industry) Key metrics vs sector peers

22

FY basis, prices as of each company's last fiscal year-end close.

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
HUM $50.90B 26.0 10.1% 0.92% 7.0% ·
UNH $299.08B 25.0 11.8% 2.7% 12.0% ·
ELV $77.37B 13.9 12.5% 2.8% 13.3% ·
CNC $20.24B -3.0 19.4% -3.4% -28.8% 7.3%
MOH $8.85B 19.5 11.8% 1.0% 10.9% ·
HQY $7.12B 34.0 9.5% 16.4% 10.1% 69.5%
CLOV · -5.1 40.3% -4.5% -26.2% ·
PGNY $2.14B 39.5 10.4% 4.5% 11.3% 23.6%
ALHC $4.03B · 46.1% -0.02% -0.52% ·

Latest News Recent headlines mentioning this company

23

My Metrics Your personal watchlist — selected rows from Full Fundamentals

26

Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Source: SEC 10-Q filed Jul 29, 2026